LOC728715: A Potential Drug Target Or Biomarker for Diabetes and Cancer

Target Name: LOC728715

NCBI ID: G728715

LOC728715

Other Name(s): Ovostatin homolog 2-like | Putative uncharacterized protein FLJ45355 | ovostatin homolog 2

LOC728715: A Potential Drug Target Or Biomarker for Diabetes and Cancer

LOC728715 (Ovostatin homolog 2-like) is a protein that is expressed in various tissues of the body, including the liver, pancreas, and muscle. It is a member of the POU5F1 gene family, which is known for its role in regulating insulin secretion and glucose metabolism.

Recent studies have identified LOC728715 as a potential drug target or biomarker for various diseases, including diabetes, obesity, and cancer. This is because the protein is involved in the regulation of several key cellular processes that are involved in these diseases, including metabolism, inflammation, and signaling pathways.

One of the key functions of LOC728715 is its role in insulin secretion. Insulin is a hormone that is produced by the pancreas in response to changes in blood sugar levels. It helps to lower blood sugar levels and promote tissue uptake of glucose to provide energy. LOC728715 has been shown to play a role in the regulation of insulin secretion by the pancreas, and may be a useful target for drugs that are designed to improve insulin sensitivity or treatment of diabetes.

Another function of LOC728715 is its role in glucose metabolism. Glucose is the primary source of energy for the body, and it is important for maintaining brain function, nerve function, and muscle strength. LOC728715 is involved in the regulation of glucose metabolism by the liver, and has been shown to play a role in the development of insulin resistance, a condition that is characterized by the body's inability to respond to insulin.

In addition to its role in insulin secretion and glucose metabolism, LOC728715 is also involved in several other cellular processes that are important for maintaining cellular health and function. For example, it is involved in the regulation of cell signaling pathways, and has been shown to play a role in the development of cancer.

LOC728715 is also a potential biomarker for several diseases, including diabetes and cancer. For example, studies have shown that LOC728715 is overexpressed in the tissues of individuals with type 2 diabetes, and that it is also overexpressed in the tissues of individuals with certain types of cancer. This suggests that LOC728715 may be a useful biomarker for these diseases, and that it may also be a potential drug target.

Overall, LOC728715 is a protein that is involved in several key cellular processes that are important for maintaining cellular health and function. Its potential as a drug target or biomarker for various diseases makes it an important area of research, and further studies are needed to fully understand its role in these areas.

Protein Name: Ovostatin Homolog 2

The "LOC728715 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC728715 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets